Activin or Follistatin: Which is More Beneficial to Support Liver Regeneration After Massive Hepatectomy?
-
- ENDO Daisuke
- Institute for Molecular and Cellular Regulation, Gunma University Division of Hepato-Billiary-Pancreatic Surgery, Graduate School of Medicine, University of Tokyo
-
- MAKU-UCHI Masatoshi
- Division of Hepato-Billiary-Pancreatic Surgery, Graduate School of Medicine, University of Tokyo
-
- KOJIMA Itaru
- Institute for Molecular and Cellular Regulation, Gunma University
この論文をさがす
抄録
The present study was conducted to compare the effects of exogenous follistatin and activin A on liver regeneration in 90% hepatectomized rats. Intraportal administration of follistatin markedly accelerated liver regeneration, and nuclear BrdU labeling and liver regeneration rate were greatly increased by follistatin. In contrast, administration of activin A attenuated liver regeneration. After 120 h of 90% hepatectomy, histological analysis showed that the hepatic architecture was restored in control and activin-treated rats. However, it was not restored in follistatin-treated rats. The serum bilirubin levels were significantly increased in follistatin-treated rats, and the serum glucose level was significantly lower in follistatin-treated rats. Although follistatin markedly accelerated liver regeneration, it reduced the function of the remnant liver. Treatment with activin A instead may be beneficial to support liver regeneration after massive hepatectomy.<br>
収録刊行物
-
- Endocrine Journal
-
Endocrine Journal 53 (1), 73-78, 2006
一般社団法人 日本内分泌学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001206297257216
-
- NII論文ID
- 130004443218
- 10020545945
-
- NII書誌ID
- AA10901436
-
- ISSN
- 13484540
- 09188959
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可